The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
89BIO INC | COM | 282559103 | 4,786,400 | 310,000 | SH | SOLE | 310,000 | 0 | 0 | ||
AEGLEA BIOTHERAPEUTICS INC | COM NEW | 00773J202 | 2,572,500 | 210,000 | SH | SOLE | 210,000 | 0 | 0 | ||
AKERO THERAPEUTICS INC | COM | 00973Y108 | 30,348,000 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
ALLAKOS INC | COM | 01671P100 | 10,555,500 | 4,650,000 | SH | SOLE | 4,650,000 | 0 | 0 | ||
ALX ONCOLOGY HLDGS INC | COM | 00166B105 | 4,800,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
AMBRX BIOPHARMA INC | SPONSORED ADS | 02290A102 | 1,322,500 | 115,000 | SH | SOLE | 115,000 | 0 | 0 | ||
ANNEXON INC | COM | 03589W102 | 12,508,000 | 5,300,000 | SH | SOLE | 5,300,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 28,530,000 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 24,726,000 | 650,000 | SH | Call | SOLE | 650,000 | 0 | 0 | |
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 4,065,402 | 544,960 | SH | SOLE | 544,960 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 10,548,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 13,185,000 | 500,000 | SH | Call | SOLE | 500,000 | 0 | 0 | |
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 15,281,000 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 7,030,000 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 7,435,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 36,825,000 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
DELCATH SYS INC | COM NEW | 24661P807 | 4,229,998 | 1,044,444 | SH | SOLE | 1,044,444 | 0 | 0 | ||
DESIGN THERAPEUTICS INC | COM | 25056L103 | 11,876,702 | 5,032,501 | SH | SOLE | 5,032,501 | 0 | 0 | ||
DYNE THERAPEUTICS INC | COM | 26818M108 | 19,532,800 | 2,180,000 | SH | SOLE | 2,180,000 | 0 | 0 | ||
ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 4,194,658 | 307,076 | SH | SOLE | 307,076 | 0 | 0 | ||
GERON CORP | COM | 374163103 | 5,830,000 | 2,750,000 | SH | SOLE | 2,750,000 | 0 | 0 | ||
GRACELL BIOTECHNOLOGIES INC | SPONSORED ADS | 38406L103 | 7,272,000 | 2,525,000 | SH | SOLE | 2,525,000 | 0 | 0 | ||
ICOSAVAX INC | COM | 45114M109 | 21,434,493 | 2,765,741 | SH | SOLE | 2,765,741 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 60,705,000 | 2,250,000 | SH | SOLE | 2,250,000 | 0 | 0 | ||
IMMATICS N.V | SHS | N44445109 | 12,159,000 | 1,050,000 | SH | SOLE | 1,050,000 | 0 | 0 | ||
IMMUNIC INC | COM | 4525EP101 | 619,140 | 421,184 | SH | SOLE | 421,184 | 0 | 0 | ||
IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 23,355,000 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 61,424,000 | 1,600,000 | SH | SOLE | 1,600,000 | 0 | 0 | ||
IO BIOTECH INC | COM | 449778109 | 696,296 | 493,827 | SH | SOLE | 493,827 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 4,550,000 | 1,000,000 | SH | Call | SOLE | 1,000,000 | 0 | 0 | |
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 8,667,000 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 19,445,350 | 115,000 | SH | SOLE | 115,000 | 0 | 0 | ||
LEAP THERAPEUTICS INC | COM NEW | 52187K200 | 488,887 | 354,266 | SH | SOLE | 354,266 | 0 | 0 | ||
LIANBIO | SPONSORED ADS | 53000N108 | 417,200 | 280,000 | SH | SOLE | 280,000 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 5,777,100 | 245,000 | SH | SOLE | 245,000 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 13,068,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
MORPHOSYS AG | SPONSORED ADS | 617760202 | 6,384,000 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 16,875,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 6,667 | 66,666 | SH | SOLE | 66,666 | 0 | 0 | ||
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 46,236,856 | 3,743,875 | SH | SOLE | 3,743,875 | 0 | 0 | ||
REPARE THERAPEUTICS INC | COM | 760273102 | 3,624,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
REPARE THERAPEUTICS INC | COM | 760273102 | 6,040,000 | 500,000 | SH | Call | SOLE | 500,000 | 0 | 0 | |
REVOLUTION MEDICINES INC | COM | 76155X100 | 6,920,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 9,170,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 40,467,750 | 1,975,000 | SH | SOLE | 1,975,000 | 0 | 0 | ||
ROIVANT SCIENCES LTD | SHS | G76279101 | 14,016,000 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 24,244,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SOLENO THERAPEUTICS INC | COM | 834203309 | 3,688,750 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 25,210,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
TYRA BIOSCIENCES INC | COM | 90240B106 | 438,877 | 31,872 | SH | SOLE | 31,872 | 0 | 0 | ||
VENTYX BIOSCIENCES INC | COM | 92332V107 | 7,814,250 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
VERVE THERAPEUTICS INC | COM | 92539P101 | 2,850,900 | 215,000 | SH | SOLE | 215,000 | 0 | 0 | ||
VIGIL NEUROSCIENCE INC | COM | 92673K108 | 1,015,422 | 188,390 | SH | SOLE | 188,390 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 16,107,000 | 1,050,000 | SH | SOLE | 1,050,000 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 15,372,000 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
ZURA BIO LTD | CLASS A ORD SHS | G9TY5A101 | 2,798,400 | 424,000 | SH | SOLE | 424,000 | 0 | 0 |